218 related articles for article (PubMed ID: 14622207)
21. Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones.
Volpicelli F; Perrone-Capano C; Da Pozzo P; Colucci-D'Amato L; di Porzio U
J Neurochem; 2004 Mar; 88(5):1283-94. PubMed ID: 15009684
[TBL] [Abstract][Full Text] [Related]
22. VIP is a transcriptional target of Nurr1 in dopaminergic cells.
Luo Y; Henricksen LA; Giuliano RE; Prifti L; Callahan LM; Federoff HJ
Exp Neurol; 2007 Jan; 203(1):221-32. PubMed ID: 16999955
[TBL] [Abstract][Full Text] [Related]
23. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury.
Le W; Conneely OM; He Y; Jankovic J; Appel SH
J Neurochem; 1999 Nov; 73(5):2218-21. PubMed ID: 10537083
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and Nurr1-deficient mice.
Baffi JS; Palkovits M; Castillo SO; Mezey E; Nikodem VM
Neuroscience; 1999; 93(2):631-42. PubMed ID: 10465447
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.
Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
J Neurosci; 1996 Jul; 16(13):4135-45. PubMed ID: 8753875
[TBL] [Abstract][Full Text] [Related]
26. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system.
Zetterström RH; Williams R; Perlmann T; Olson L
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):111-20. PubMed ID: 8883941
[TBL] [Abstract][Full Text] [Related]
27. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons.
Kele J; Simplicio N; Ferri AL; Mira H; Guillemot F; Arenas E; Ang SL
Development; 2006 Feb; 133(3):495-505. PubMed ID: 16410412
[TBL] [Abstract][Full Text] [Related]
28. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum.
Caudle WM; Richardson JR; Wang M; Miller GW
Neurotoxicology; 2005 Aug; 26(4):721-728. PubMed ID: 16112329
[TBL] [Abstract][Full Text] [Related]
29. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism.
Sacchetti P; Mitchell TR; Granneman JG; Bannon MJ
J Neurochem; 2001 Mar; 76(5):1565-72. PubMed ID: 11238740
[TBL] [Abstract][Full Text] [Related]
30. Dopamine neuron agenesis in Nurr1-deficient mice.
Zetterström RH; Solomin L; Jansson L; Hoffer BJ; Olson L; Perlmann T
Science; 1997 Apr; 276(5310):248-50. PubMed ID: 9092472
[TBL] [Abstract][Full Text] [Related]
31. Dopaminergic differentiation of human embryonic stem cells.
Zeng X; Cai J; Chen J; Luo Y; You ZB; Fotter E; Wang Y; Harvey B; Miura T; Backman C; Chen GJ; Rao MS; Freed WJ
Stem Cells; 2004; 22(6):925-40. PubMed ID: 15536184
[TBL] [Abstract][Full Text] [Related]
32. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.
Haycock JW; Becker L; Ang L; Furukawa Y; Hornykiewicz O; Kish SJ
J Neurochem; 2003 Nov; 87(3):574-85. PubMed ID: 14535941
[TBL] [Abstract][Full Text] [Related]
33. Nurr1 in Parkinson's disease and related disorders.
Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.
Bannon MJ; Pruetz B; Manning-Bog AB; Whitty CJ; Michelhaugh SK; Sacchetti P; Granneman JG; Mash DC; Schmidt CJ
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6382-5. PubMed ID: 11959923
[TBL] [Abstract][Full Text] [Related]
35. Nurr1 co-localizes with EphB1 receptors in the developing ventral midbrain, and its expression is enhanced by the EphB1 ligand, ephrinB2.
Calò L; Spillantini M; Nicoletti F; Allen ND
J Neurochem; 2005 Jan; 92(2):235-45. PubMed ID: 15663472
[TBL] [Abstract][Full Text] [Related]
36. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
37. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.
Simon HH; Bhatt L; Gherbassi D; Sgadó P; Alberí L
Ann N Y Acad Sci; 2003 Jun; 991():36-47. PubMed ID: 12846972
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
Grothe C; Timmer M; Scholz T; Winkler C; Nikkhah G; Claus P; Itoh N; Arenas E
Neurobiol Dis; 2004 Nov; 17(2):163-70. PubMed ID: 15474354
[TBL] [Abstract][Full Text] [Related]
39. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
40. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice.
Le W; Conneely OM; Zou L; He Y; Saucedo-Cardenas O; Jankovic J; Mosier DR; Appel SH
Exp Neurol; 1999 Oct; 159(2):451-8. PubMed ID: 10506516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
